HomeOpen Access NewsAutoimmune diseases

autoimmune diseases

Subscribe to Updates

New global standard set to improve coeliac disease diagnosis

Diseases & Conditions
A newly developed certified reference material hopes to improve the accuracy of medical tests used worldwide across laboratories.

Research says COVID vaccines work for 90% of immunosuppressed people

Health & Social Care
New research finds that COVID vaccines work for 90% of people who are currently immunosuppressed due to their medication.

Immunocompromised patients show low immune response after second vaccine

Diseases & Conditions
According to the OCTAVE study, immunocompromised patients presented low immune responses after two doses of the same COVID-19 vaccine.

Clinical trial to test third COVID-19 vaccine for people with weakened immune systems

Health & Social Care
A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.

Campaigners call for approval of life saving COVID-19 antibody treatments

Health & Social Care
A group of patient bodies, charities and senior clinicians have urged the Government to approve the use of life-saving COVID-19 antibody treatments.

Immune system research: Vaccines and immunotherapeutics

Research & Innovation
Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.

Curative approach to severe autoimmune diseases

Diseases & Conditions
Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

Childhood trauma linked to multiple sclerosis development

Diseases & Conditions
Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.

Scientists use immune system to predict likelihood of long COVID

Health & Social Care
Cambridge researchers have published their findings on how the immune system could be an early clue for the later development of severe or long COVID.

The beginning of the end for Type 1 diabetes: A new view from immunotherapy science

Diseases & Conditions
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.

Rethinking Type 1 diabetes with a radically new immunotherapy approach

Research & Innovation
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd